SuanNutra to Acquire Specialty Ingredients Businesses from IFF

SuanNutra, a global supplier of functional ingredients, along with its parent company Carbyne Equity Partners, has entered into an agreement to acquire a portfolio of specialty ingredients businesses from IFF.

The businesses will merge with SuanNutra’s existing operations to create an enlarged group, with the transaction expected to be completed by the end of 2026.

The incoming businesses will bring an expanded range of branded ingredients and botanical extraction, fermented vitamins and minerals, plant-derived natural colors, antioxidants, and flavors.

The manufacturing footprint includes botanical extraction in Spain, Slovenia, and Peru, and fermentation in the U.S. The merged group will have 700 employees serving more than 1,200 customers in over 60 countries. There will be no interruptions in operations, SuanNutra reported, and the group will continue to expand its capacity, R&D, and innovation.

“The engaged, experienced people in these businesses know the products and customers deeply, and that expertise is central to everything we aspire to achieve,” said Atnhony Weston, group CEO of SuanNutra. “Together we will build, grow, and transform this group into a stronger partner for our customers offering manufacturing at source, clinically proven ingredients, and a broad natural portfolio across nutraceuticals and food enhancement.”

“Clinically supported branded ingredients are where this industry is heading: proven actives with the science to stand behind them,” said Yoni Glickman, non-executive chairman of SuanNutra. “This expansion puts SuanNutra at the forefront of this transition. The move from artificial colors and preservatives to natural, scientifically substantiated ingredients is reshaping the food and health industries faster than ever.”

“SuanNutra has a clear strategy and a management team that understands these businesses and their markets,” said Markus Petersen, managing partner of Carbyne Equity Partners. “This merger creates a botanical-based ingredients group of genuine scale and scientific credibility, and we are pleased to back the team in building it. We look forward to the opportunities these teams and SuanNutra will create together.”

“Specialty ingredients are at the heart of Carbyne’s investment strategy,” said Mai Karas, investment director of Carbyne Equity Partners. “This transaction brings a global range of natural ingredients into the group and deepens our focus on the sector.”